The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis
Conclusions:
This analysis suggests no difference between duloxetine and other post-first line oral treatments for osteoarthritis (OA) in total WOMAC score after approximately 12 weeks of treatment. Significant results for 3 compounds (1 better and 2 worse) were not consistent across performed analyses.
Source: Epidemiologic Perspectives and Innovations - Category: Epidemiology Authors: Julie MyersRonald C WielageBaoguang HanKaren PriceJames GahnMarie-Ange PagetMichael Happich Source Type: research
More News: Acetaminophen | Cymbalta | Databases & Libraries | Epidemiology | Lortab | Osteoarthritis | Oxycodone | OxyContin | Percocet | Study | Tramadol | Ultracet | Universities